Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
2022 ASCO Genitourinary (GU) Cancers Symposium, Veracyte Announces New Data at ASCO GU 2022, phase 3 study evaluating the Decipher genomic classifier.
Source: urotoday.com